COVID-19: Vaccines and Therapeutics
The Food and Drug Administration late last night granted an emergency use authorization (EUA) to Pfizer, Inc. for its BNT162b2 mRNA COVID-19 vaccine, paving the way for its immediate administration across the country. Health care workers and nursing home residents will receive first priority and…
The Food and Drug Administration today granted an emergency use authorization to Pfizer, Inc. for its BNT162b2 mRNA COVID-19 vaccine, paving the way for its immediate administration across the country. The vaccine is administered in two doses, 21 days apart, and requires ultracold (minus-70 degrees…
AHA statement on FDA Emergency Use Authorization of Pfizer COVID-19 Vaccine from President and CEO Rick Pollack.
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee Dec. 10 recommended the approval of Pfizer, Inc.’s BNT162b2 mRNA COVID-19 vaccine. The panel voted 17-4, with one abstention, that FDA issue an emergency use authorization.
The Department of Defense announced a phased plan for the distribution and administration of initial and subsequent COVID-19 vaccine allocations to populations of DoD uniformed service members, including members of the National Guard; dependents; retirees; civilian employees; and select DoD…
Peer-reviewed data for Pfizer Inc.’s BNT162b2 mRNA COVID-19 vaccine candidate was published by the New England Journal of Medicine, confirming its safety and efficacy.
The AHA Friday, Dec. 11 at 3 p.m. ET will host a call with officials from the Centers for Disease Control and Prevention on COVID-19 vaccine distributions.
The Food and Drug Administration released a briefing document on Pfizer’s BNT162b2 COVID-19 vaccine candidate that confirms the drug maker’s claims of the vaccine’s efficacy and safety.
The National Urban League, an AHA strategic alliance partner, Dec. 8 will host a conversation with Anthony Fauci, M.D., the director of the National Institute of Allergy and Infectious Diseases, to address vaccine hesitancy in communities of color.
The Cybersecurity and Infrastructure Security Agency alerted organizations to a global phishing and spearphishing campaign targeting the COVID-19 vaccine cold chain, the part of the supply chain used to store and transport a vaccine at safe temperatures.